                               SEQUENCE LISTING

<110> WISCONSIN ALUMNI RESEARCH FOUNDATION
 
<120> POLYPLEX DELIVERY SYSTEM FOR PROTEINS, NUCLEIC ACIDS AND 
      PROTEIN/NUCLEIC ACID COMPLEXES

<130> 032026-1394

<140> PCT/US2019/019051
<141> 2019-02-21

<150> 62/634,156
<151> 2018-02-22

<160> 43    

<170> PatentIn version 3.5

<210> 1
<211> 12
<212> PRT
<213> Human immunodeficiency virus

<400> 1
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Gln 
1               5                   10          


<210> 2
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Lys Leu Ala Leu Lys Leu Ala Leu Lys Ala Leu Lys Ala Ala Leu Lys 
1               5                   10                  15      


Leu Ala 
        


<210> 3
<211> 15
<212> PRT
<213> Drosophila sp.

<400> 3
Arg Gln Ile Lys Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15  


<210> 4
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Arg Gln Ile Arg Ile Trp Phe Gln Asn Arg Arg Met Arg Trp Arg Arg 
1               5                   10                  15      


<210> 5
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Cys Ser Ile Pro Pro Glu Val Lys Phe Asn Lys Pro Phe Val Tyr Leu 
1               5                   10                  15      


Ile 
    


<210> 6
<211> 13
<212> PRT
<213> Rana temporaria

<400> 6
Phe Val Gln Trp Phe Ser Lys Phe Leu Gly Arg Ile Leu 
1               5                   10              


<210> 7
<211> 10
<212> PRT
<213> Maurus palmatus

<400> 7
Gly Asp Cys Leu Pro His Leu Lys Leu Cys 
1               5                   10  


<210> 8
<211> 18
<212> PRT
<213> Mus sp.

<400> 8
Leu Leu Ile Ile Leu Arg Arg Arg Ile Arg Lys Gln Ala His Ala His 
1               5                   10                  15      


Ser Lys 
        


<210> 9
<211> 24
<212> PRT
<213> Homo sapiens

<400> 9
Leu Gly Thr Tyr Thr Gln Asp Phe Asn Lys Phe His Thr Phe Pro Gln 
1               5                   10                  15      


Thr Ala Ile Gly Val Gly Ala Pro 
            20                  


<210> 10
<211> 30
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Neurturin sequence

<400> 10
Gly Ala Ala Glu Ala Ala Ala Arg Val Tyr Asp Leu Gly Leu Arg Arg 
1               5                   10                  15      


Leu Arg Gln Arg Arg Arg Leu Arg Arg Glu Arg Val Arg Ala 
            20                  25                  30  


<210> 11
<211> 18
<212> PRT
<213> Drosophila sp.

<400> 11
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Gly Gly 
        


<210> 12
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 12
Arg Arg Arg Gln Arg Arg Lys Lys Arg Gly Gly Asp Ile Met Gly Glu 
1               5                   10                  15      


Trp Gly Asn Glu Ile Phe Gly Ala Ile Ala Gly Phe Leu Gly 
            20                  25                  30  


<210> 13
<211> 11
<212> PRT
<213> Human immunodeficiency virus

<400> 13
Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210> 14
<211> 18
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      SynB1 sequence

<400> 14
Arg Gly Gly Arg Leu Ser Tyr Ser Arg Arg Arg Phe Ser Thr Ser Thr 
1               5                   10                  15      


Gly Arg 
        


<210> 15
<211> 10
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      SynB3 sequence

<400> 15
Arg Arg Leu Ser Tyr Ser Arg Arg Arg Phe 
1               5                   10  


<210> 16
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Pro Ile Arg Arg Arg Lys Lys Leu Arg Arg Leu 
1               5                   10      


<210> 17
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Arg Arg Gln Arg Arg Thr Ser Lys Leu Met Lys Arg 
1               5                   10          


<210> 18
<211> 15
<212> PRT
<213> Flock House virus

<400> 18
Arg Arg Arg Arg Asn Arg Thr Arg Arg Asn Arg Arg Arg Val Arg 
1               5                   10                  15  


<210> 19
<211> 19
<212> PRT
<213> Brome Mosaic virus

<400> 19
Lys Met Thr Arg Ala Gln Arg Arg Ala Ala Ala Arg Arg Asn Arg Trp 
1               5                   10                  15      


Thr Ala Arg 
            


<210> 20
<211> 13
<212> PRT
<213> Human T-cell leukemia virus II

<400> 20
Thr Arg Arg Gln Arg Thr Arg Arg Ala Arg Arg Asn Arg 
1               5                   10              


<210> 21
<211> 13
<212> PRT
<213> Human immunodeficiency virus

<400> 21
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210> 22
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210> 23
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Lys Ile Leu 
            20                  25          


<210> 24
<211> 27
<212> PRT
<213> Homo sapiens

<400> 24
Met Gly Leu Gly Leu His Leu Leu Val Leu Ala Ala Ala Leu Gln Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Lys Lys Arg Lys Val 
            20                  25          


<210> 25
<211> 27
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      FBP sequence

<400> 25
Gly Ala Leu Phe Leu Gly Trp Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Lys Lys Arg Lys Val 
            20                  25          


<210> 26
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Gly Ala Leu Phe Leu Gly Phe Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Lys Lys Arg Lys Val 
            20                  25          


<210> 27
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Gly Ala Leu Phe Leu Gly Phe Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Ser Lys Arg Lys Val 
            20                  25          


<210> 28
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Lys Glu Thr Trp Trp Glu Thr Trp Trp Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Lys Val 
            20      


<210> 29
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Lys Glu Thr Trp Phe Glu Thr Trp Phe Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Lys Val 
            20      


<210> 30
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(17)
<223> This sequence may encompass 4-17 residues

<400> 30
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Arg 
    


<210> 31
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(17)
<223> This sequence may encompass 4-17 residues

<400> 31
Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
1               5                   10                  15      


Lys 
    


<210> 32
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Aminocaproic acid

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Aminocaproic acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Aminocaproic acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Aminocaproic acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Aminocaproic acid

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Aminocaproic acid

<400> 32
Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg 
1               5                   10              


<210> 33
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Aminobutyric acid

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Aminobutyric acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Aminobutyric acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Aminobutyric acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Aminobutyric acid

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Aminobutyric acid

<400> 33
Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg Xaa Arg 
1               5                   10              


<210> 34
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Arg Gly Arg Gly Arg Gly Arg Gly Arg Gly Arg Gly Arg 
1               5                   10              


<210> 35
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Arg Met Arg Met Arg Met Arg Met Arg Met Arg Met Arg 
1               5                   10              


<210> 36
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 36
Arg Thr Arg Thr Arg Thr Arg Thr Arg Thr Arg Thr Arg 
1               5                   10              


<210> 37
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 37
Arg Ser Arg Ser Arg Ser Arg Ser Arg Ser Arg Ser Arg 
1               5                   10              


<210> 38
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 38
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10  


<210> 39
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 39
Arg Ala Arg Ala Arg Ala Arg Ala Arg Ala Arg Ala Arg 
1               5                   10              


<210> 40
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 40
Arg Arg Arg Arg Arg Arg Arg 
1               5           


<210> 41
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 41
Pro Lys Lys Lys Lys Arg Lys Val 
1               5               


<210> 42
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 42
ggagccgtac atgaactgag                                                   20


<210> 43
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 43
gctgaagcac tgcacgccat                                                   20


